Diagnosis and Management of Ovarian Cancer Biology Essay
This slideshow explains what ovarian cancer is, where different types of ovarian cancer can arise, and which type of ovarian cancer is most common. You can learn about risk factors, symptoms of ovarian cancer and current chemotherapy algorithms. Ovarian cancer is the most fatal malignant disease of the female genital organs. The pharmacology of ovarian cancer depends on the stage of the disease according to the criteria of the International Federation of Gynecological Oncology, FIGO, and includes cytoreductive surgery and increased levels of CA-125, a glycosylated protein found in the blood and on the surface of some ovarian cancers. cancer cells 9 may indicate ovarian cancer 10. Its usefulness is limited by its poor sensitivity and specificity 11. In fact, serum CA is not increased, but in ovarian carcinomas, CA is increased. Gynecologists are involved in various treatment options for treating ovarian cancer. The treatment regimen may include surgical interventions, chemotherapy and radiation therapy. At the same time, they actively use medications to relieve symptoms, improve the overall condition and eradicate disorders caused by the. There is evidence that cancers with PIK3CA mutations, such as endometrioid and clear cell ovarian cancer, are upregulated in nuclear factor-kappaB NF. -κB pathways may drive IL-6 expression, potentially linking known associations between increased NF-κB expression and poor prognosis in ovarian cancer Background: This study aimed to compare deep learning with assessments of radiologists to diagnose ovarian cancer using MRI. Methods: In this retrospective study, patients with pathologically confirmed ovarian carcinomas or borderline tumors were treated in patients with non-malignant lesions who underwent interim MRI. Ovarian cancer is one of the most common causes of death in women because survival is highly dependent on the stage of the disease. Ovarian cancer is usually diagnosed at a late stage because it is usually asymptomatic in the early stages. Genomic instability is one of the hallmarks of ovarian cancer. Introduction. Cancer is the most common cause of death in most parts of the world and is currently the most common barrier to achieving desired life expectancy in most countries. Cancer is one of the most common gynecological cancers, ranking third after cervical and uterine cancer. also has the worst; Ovarian cancer is the deadliest gynecological malignancy. The majority of patients diagnosed with advanced ovarian cancer will relapse, after which additional therapies can be administered, but for the most part these are not curative. As such, there is a need to develop new therapeutic options for ovarian cancer. Ovarian cancer is one of the most common pathologies in gynecology. This malignancy can be divided into major groups: epithelial and non-epithelial. Because epithelial ovarian cancer (EOC) is the most commonly diagnosed, this article focuses on the latest therapies related to this disease. Because of the difficult diagnosis, EOC is. Exosomes can prepare distant tissue sites to receive future metastases and their release can be mediated by the tumor microenvironment, for example hypoxia. Ovarian cancer-derived exosomes have unique characteristics that could be used as biomarkers to better detect and treat the disease,,